{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:04:58Z","timestamp":1790730298979,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11886-020-1261-2","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T23:02:55Z","timestamp":1580252575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification"],"prefix":"10.1007","volume":"22","author":[{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasken","family":"Dilsizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"1261_CR1","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jacc.2018.07.106","volume":"72","author":"KL Gould","year":"2018","unstructured":"Gould KL, Johnson NP. Coronary physiology beyond coronary flow reserve in microvascular angina: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:2642\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR2","unstructured":"\u2022 Schindler TH, Dilsizian V. Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis. JACC Cardiovasc Imaging. 2019; in press Recent review paper on microvascular dysfunction with comparison of the different non-invasive modalities to assess MBF."},{"key":"1261_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12350-017-1110-x","volume":"25","author":"VL Murthy","year":"2018","unstructured":"\u2022\u2022 Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: joint position paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018;25:269\u201397 Recent joint position paper of the leading nuclear cardiology societies with extensive and critical literature review as well as procedural recommendations for PET MPI and MBF quantification.","journal-title":"J Nucl Cardiol"},{"key":"1261_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11886-019-1096-x","volume":"21","author":"M Pelletier-Galarneau","year":"2019","unstructured":"Pelletier-Galarneau M, Martineau P, El Fakhri G. Quantification of PET myocardial blood flow. Curr Cardiol Rep. 2019;21:11.","journal-title":"Curr Cardiol Rep"},{"key":"1261_CR5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2012.06.007","volume":"5","author":"VL Murthy","year":"2012","unstructured":"Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Dorbala S, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012;5:1025\u201334.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1261_CR6","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","volume":"124","author":"VL Murthy","year":"2011","unstructured":"Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215\u201324.","journal-title":"Circulation"},{"key":"1261_CR7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2009.02.069","volume":"54","author":"BA Herzog","year":"2009","unstructured":"Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jacc.2011.01.065","volume":"58","author":"MC Ziadi","year":"2011","unstructured":"Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJW, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1261_CR9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jcmg.2010.04.007","volume":"3","author":"TH Schindler","year":"2010","unstructured":"Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. J Am Coll Cardiol Img. 2010;3(6):623\u201340.","journal-title":"J Am Coll Cardiol Img"},{"key":"1261_CR10","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.nuclcard.2007.10.001","volume":"14","author":"RP Ward","year":"2007","unstructured":"Ward RP, Al-Mallah MH, Grossman GB, Hansen CL, Hendel RC, Kerwin TC, et al. American Society of Nuclear Cardiology review of the ACCF\/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). J Nucl Cardiol. 2007;14:e26\u201338.","journal-title":"J Nucl Cardiol"},{"key":"1261_CR11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jcmg.2012.10.006","volume":"5","author":"V Dilsizian","year":"2012","unstructured":"Dilsizian V, Taillefer R. Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18 labeled myocardial perfusion tracers? J Am Coll Cardiol Img. 2012;5:1269\u201384.","journal-title":"J Am Coll Cardiol Img"},{"issue":"9","key":"1261_CR12","first-page":"491","volume":"17","author":"MA Lodge","year":"2005","unstructured":"Lodge MA, Braess H, Mahmood F, Suh JD, Englar N, Bacharach SL, et al. Developments in nuclear cardiology: transition from single photon emission computed tomography to positron emission tomography-computed tomography. J Invasive Cardiol. 2005;17(9):491\u20136.","journal-title":"J Invasive Cardiol"},{"key":"1261_CR13","doi-asserted-by":"publisher","unstructured":"Pieper J, Patel VN, Escolero S, Nelson JR, Poitrasson-Rivi\u00e8re A, Shreves CK, Freiburger N, Hubers D, Rothley J, Corbett JR, Oliverio J, Ficaro EP, Weinberg RL, Murthy VL Initial clinical experience of N13-ammonia myocardial perfusion PET\/CT using a compact superconducting production system. J Nucl Cardiol [Internet]. 2019 [cited 2019 Sep 17]; Available from: https:\/\/doi.org\/10.1007\/s12350-019-01886-7, 1, 5.","DOI":"10.1007\/s12350-019-01886-7"},{"key":"1261_CR14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0735-1097(98)00630-5","volume":"33","author":"AN Kitsiou","year":"1999","unstructured":"Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, Summers RM, Quyyumi AA, et al. 13N-Ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol. 1999;33:678\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR15","doi-asserted-by":"crossref","unstructured":"Klein R, deKemp RA. 82Rb is the best flow tracer for high-volume sites. Annals of Nuclear Cardiology 2019;5:53\u201362.","DOI":"10.17996\/anc.19-00105"},{"key":"1261_CR16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","volume":"23","author":"V Dilsizian","year":"2016","unstructured":"Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23:1187\u2013226.","journal-title":"J Nucl Cardiol"},{"key":"1261_CR17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2967\/jnumed.112.112219","volume":"54","author":"RA Dekemp","year":"2013","unstructured":"Dekemp RA, Declerck J, Klein R, Pan X-B, Nakazato R, Tonge C, et al. Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET\/CT and a 1-tissue-compartment model of 82Rb kinetics. J Nucl Med. 2013;54:571\u20137.","journal-title":"J Nucl Med"},{"key":"1261_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","volume":"12","author":"PG Camici","year":"2015","unstructured":"Camici PG, d\u2019Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol. 2015;12:48\u201362.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"1261_CR19","first-page":"47A","volume":"21","author":"AA Quyyumi","year":"1993","unstructured":"Quyyumi AA, Arrighi JA, Diodati JG, Marin-Neto JA, Bonow RO, Dilsizian V. Vasoconstriction as a cause of myocardial ischemia during daily life: comparison of ambulatory monitoring with blood flow changes during exercise rubidium-82 positron emission tomography. J Am Coll Cardiol. 1993;21(2):47A.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.107.033530","volume":"49","author":"MR Vesely","year":"2008","unstructured":"Vesely MR, Dilsizian V. Nuclear cardiac stress testing in the era of molecular imaging. J Nucl Med. 2008;49:399\u2013413.","journal-title":"J Nucl Med"},{"key":"1261_CR21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11886-010-0165-y","volume":"13","author":"MR Vesely","year":"2011","unstructured":"Vesely MR, Dilsizian V. Microvascular angina: assessment of coronary blood flow, flow reserve and metabolism. Curr Cardiol Rep. 2011;13:151\u20138.","journal-title":"Curr Cardiol Rep"},{"key":"1261_CR22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0735-1097(94)00507-M","volume":"25","author":"JC Kaski","year":"1995","unstructured":"Kaski JC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA, Rosano GM. Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol. 1995;25:807\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","volume":"250","author":"P Ong","year":"2018","unstructured":"\u2022\u2022 Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16\u201320 Landmark expert consensus paper establishing diagnostic criteria for microvascular angina.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1261_CR24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1071-3581(00)90042-4","volume":"7","author":"V Dilsizian","year":"2000","unstructured":"Dilsizian V. The role of myocardial perfusion imaging in vascular endothelial dysfunction. J Nucl Cardiol. 2000;7(2):180\u20134.","journal-title":"J Nucl Cardiol"},{"key":"1261_CR25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","volume":"169","author":"M Gulati","year":"2009","unstructured":"Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women\u2019s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169:843\u201350.","journal-title":"Arch Intern Med"},{"key":"1261_CR26","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2017.09.016","volume":"70","author":"A Aziz","year":"2017","unstructured":"Aziz A, Hansen HS, Sechtem U, Prescott E, Ong P. Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries. J Am Coll Cardiol. 2017;70:2349\u201358.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijcard.2019.02.038","volume":"291","author":"K Sato","year":"2019","unstructured":"Sato K, Takahashi J, Odaka Y, Suda A, Sueda S, Teragawa H, et al. Clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina: ethnic differences detected in an international comparative study. Int J Cardiol. 2019;291:13\u20138.","journal-title":"Int J Cardiol"},{"key":"1261_CR28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","volume":"8","author":"JD Sara","year":"2015","unstructured":"Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv. 2015;8:1445\u201353.","journal-title":"JACC Cardiovasc Interv"},{"key":"1261_CR29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830\u201340.","journal-title":"N Engl J Med"},{"key":"1261_CR30","doi-asserted-by":"crossref","unstructured":"Godo S, Corban MT, Toya T, Gulati R, Lerman LO, Lerman A. Association of coronary microvascular endothelial dysfunction with vulnerable plaque characteristics in early coronary atherosclerosis. EuroIntervention. 2019;","DOI":"10.1016\/S0735-1097(19)32028-5"},{"key":"1261_CR31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0735-1097(93)90193-5","volume":"22","author":"V Dilsizian","year":"1993","unstructured":"Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:796\u2013804.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR32","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jcmg.2010.07.013","volume":"3","author":"V Dilsizian","year":"2010","unstructured":"Dilsizian V, Panza JA, Bonow RO. Myocardial perfusion imaging in hypertrophic cardiomyopathy. J Am Coll Cardiol Img. 2010;3:1078\u201380.","journal-title":"J Am Coll Cardiol Img"},{"issue":"1","key":"1261_CR33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12350-010-9279-2","volume":"18","author":"J Shirani","year":"2010","unstructured":"Shirani J, Dilsizian V. Nuclear cardiac imaging in hypertrophic cardiomyopathy. J Nucl Cardiol. 2010;18(1):123\u201334.","journal-title":"J Nucl Cardiol"},{"key":"1261_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","volume":"391","author":"R Al-Lamee","year":"2018","unstructured":"Al-Lamee R, Thompson D, Dehbi H-M, Sen S, Tang K, Davies J, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391:31\u201340.","journal-title":"Lancet."},{"key":"1261_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnumed.117.206334","volume":"59","author":"V Dilsizian","year":"2018","unstructured":"Dilsizian V, Erario M. Is exercise treadmill time or reduction in myocardial ischemia the appropriate primary endpoint to assess success of percutaneous coronary intervention in stable angina (ORBITA)? J Nucl Med. 2018;59:1\u20132.","journal-title":"J Nucl Med"},{"key":"1261_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.04.061","volume":"266","author":"D Corcoran","year":"2018","unstructured":"\u2022\u2022 Corcoran D, Young R, Adlam D, McConnachie A, Mangion K, Ripley D, et al. Coronary microvascular dysfunction in patients with stable coronary artery disease: the CE-MARC 2 coronary physiology sub-study. Int J Cardiol. 2018;266:7\u201314 Sub-study of the CR-MARC 2 study demonstrating that coronary microvascular dysfunction is highly prevalent in patients with angina.","journal-title":"Int J Cardiol"},{"key":"1261_CR37","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","volume":"72","author":"TJ Ford","year":"2018","unstructured":"Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol. 2018;72:2841\u201355.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR38","first-page":"e007889","volume":"12","author":"N Takeshi","year":"2019","unstructured":"Takeshi N, Tadashi M, Giovanni C, Shah Sonia V, Yuhei K, Fran\u00e7ois D, et al. Prognostic value of coronary microvascular function measured immediately after percutaneous coronary intervention in stable coronary artery disease. Circulation: Cardiovascular Interventions. 2019;12:e007889.","journal-title":"Circulation: Cardiovascular Interventions"},{"key":"1261_CR39","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1093\/eurheartj\/ehy529","volume":"39","author":"TJ Ford","year":"2018","unstructured":"Ford TJ, Rocchiccioli P, Good R, McEntegart M, Eteiba H, Watkins S, et al. Systemic microvascular dysfunction in microvascular and vasospastic angina. Eur Heart J. 2018;39:4086\u201397.","journal-title":"Eur Heart J"},{"key":"1261_CR40","first-page":"e891","volume":"139","author":"E Tamis-Holland Jacqueline","year":"2019","unstructured":"Tamis-Holland Jacqueline E, Hani J, Reynolds Harmony R, Stefan A, Brilakis Emmanouil S, Brown Todd M, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139:e891\u2013908.","journal-title":"Circulation"},{"issue":"14","key":"1261_CR41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2014.04.086","volume":"64","author":"TH Schindler","year":"2014","unstructured":"Schindler TH, Dilsizian V. PET-determined hyperemic myocardial blood flow: further progress to clinical application. J Am Coll Cardiol. 2014;64(14):1476\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR42","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/CIRCULATIONAHA.115.018089","volume":"133","author":"H Gewirtz","year":"2016","unstructured":"Gewirtz H, Dilsizian V. Integration of quantitative PET absolute myocardial blood flow in the clinical management of coronary artery disease. Circulation. 2016;133:2180\u201396.","journal-title":"Circulation"},{"key":"1261_CR43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.CIR.88.1.62","volume":"88","author":"J Czernin","year":"1993","unstructured":"Czernin J, M\u00fcller P, Chan S, Brunken RC, Porenta G, Krivokapich J, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 1993;88:62\u20139.","journal-title":"Circulation."},{"key":"1261_CR44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2967\/jnumed.108.054395","volume":"50","author":"RA Tio","year":"2009","unstructured":"Tio RA, Dabeshlim A, Siebelink H-MJ, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med. 2009;50:214\u20139.","journal-title":"J Nucl Med"},{"key":"1261_CR45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2967\/jnumed.110.084954","volume":"52","author":"RHJA Slart","year":"2011","unstructured":"Slart RHJA, Zeebregts CJ, Hillege HL, de Sutter J, Dierckx RAJO, van Veldhuisen DJ, et al. Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor. J Nucl Med. 2011;52:873\u20139.","journal-title":"J Nucl Med"},{"key":"1261_CR46","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","volume":"126","author":"VL Murthy","year":"2012","unstructured":"Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858\u201368.","journal-title":"Circulation."},{"key":"1261_CR47","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1681\/ASN.2015030301","volume":"27","author":"NR Shah","year":"2016","unstructured":"\u2022 Shah NR, Charytan DM, Murthy VL, Skali Lami H, Veeranna V, Cheezum MK, et al. Prognostic value of coronary flow reserve in patients with dialysis-dependent ESRD. J Am Soc Nephrol. 2016;27:1823\u20139 Study establishing the independent prognostic value of flow quantification with PET in patients with dialysis-dependent end-stage renal disease.","journal-title":"J Am Soc Nephrol"},{"key":"1261_CR48","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/01.CIR.92.4.796","volume":"92","author":"D Neglia","year":"1995","unstructured":"Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetti A, Pratali L, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 1995;92:796\u2013804.","journal-title":"Circulation"},{"key":"1261_CR49","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ehjci\/jev012","volume":"16","author":"MD Majmudar","year":"2015","unstructured":"Majmudar MD, Murthy VL, Shah RV, Kolli S, Mousavi N, Foster CR, et al. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015;16:900\u20139.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1261_CR50","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00259-016-3603-2","volume":"44","author":"R Sciagr\u00e0","year":"2017","unstructured":"\u2022 Sciagr\u00e0 R, Calabretta R, Cipollini F, Passeri A, Castello A, Cecchi F, et al. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study. Eur J Nucl Med Mol Imaging. 2017;44:866\u201375 Study establishing the independent prognostic value of flow quantification with PET in patients with hypertrophic cardiomyopathy.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1261_CR51","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","volume":"47","author":"I Olivotto","year":"2006","unstructured":"Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2006;47:1043\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR52","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","volume":"349","author":"F Cecchi","year":"2003","unstructured":"Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027\u201335.","journal-title":"N Engl J Med"},{"key":"1261_CR53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.98.13.1291","volume":"98","author":"GS Huggins","year":"1998","unstructured":"Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation. 1998;98:1291\u20136.","journal-title":"Circulation."},{"key":"1261_CR54","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1161\/01.CIR.99.22.2871","volume":"99","author":"D Baller","year":"1999","unstructured":"Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation. 1999;99:2871\u20135.","journal-title":"Circulation."},{"key":"1261_CR55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.99.4.475","volume":"99","author":"M Guethlin","year":"1999","unstructured":"Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation. 1999;99:475\u201381.","journal-title":"Circulation."},{"key":"1261_CR56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1067\/mnc.2001.115517","volume":"8","author":"I Yokoyama","year":"2001","unstructured":"Yokoyama I, Yonekura K, Inoue Y, Ohtomo K, Nagai R. Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance. J Nucl Cardiol. 2001;8:445\u201351.","journal-title":"J Nucl Cardiol"},{"key":"1261_CR57","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0002-9149(02)02363-9","volume":"89","author":"SK Bennett","year":"2002","unstructured":"Bennett SK, Smith MF, Gottlieb SS, Fisher ML, Bacharach SL, Dilsizian V. Effect of Metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or non-ischemic cardiomyopathy. Am J Cardiol. 2002;89:1431\u20134.","journal-title":"Am J Cardiol"},{"key":"1261_CR58","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2007.07.070","volume":"50","author":"RP Naoumova","year":"2007","unstructured":"Naoumova RP, Kindler H, Leccisotti L, Mongillo M, Khan MT, Neuwirth C, et al. Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 2007;50:2051\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1261_CR59","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1093\/eurheartj\/ehp482","volume":"30","author":"TH Schindler","year":"2009","unstructured":"Schindler TH, Cadenas J, Facta AD, Li Y, Olschewski M, Sayre J, et al. Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus. Eur Heart J. 2009;30:3064\u201373.","journal-title":"Eur Heart J"},{"key":"1261_CR60","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/HJH.0b013e328340a08e","volume":"29","author":"D Neglia","year":"2011","unstructured":"Neglia D, Fommei E, Varela-Carver A, Mancini M, Ghione S, Lombardi M, et al. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. J Hypertens. 2011;29:364\u201372.","journal-title":"J Hypertens"},{"key":"1261_CR61","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/eht085","volume":"34","author":"A Quercioli","year":"2013","unstructured":"Quercioli A, Montecucco F, Pataky Z, Thomas A, Ambrosio G, Staub C, et al. Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. Eur Heart J. 2013;34:2063\u201373.","journal-title":"Eur Heart J"},{"issue":"1","key":"1261_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11886-013-0433-8","volume":"16","author":"I Valenta","year":"2014","unstructured":"Valenta I, Dilsizian V, Querciolo A, Ambrosio G, Wahl R, Schindler TH. Impact of obesity and bariatric surgery on metabolism and coronary circulatory function. Curr Cardiol Rep. 2014;16(1):433.","journal-title":"Curr Cardiol Rep"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-1261-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-020-1261-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-1261-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:19:48Z","timestamp":1611706788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-020-1261-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-1261-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"28 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Matthieu Pelletier-Galarneau and Vasken Dilsizian declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"9"}}